Literature DB >> 28912624

Corrigendum to "Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis".

L Durko1, W Wlodarski1, O Stasikowska-Kanicka2, M Wagrowska-Danilewicz2, M Danilewicz3, P Hogendorf4, J Strzelczyk4, E Malecka-Panas1.   

Abstract

[This corrects the article DOI: 10.1155/2017/3276806.].

Entities:  

Year:  2017        PMID： 28912624      PMCID： PMC5585567          DOI： 10.1155/2017/9617615

Source DB:  PubMed          Journal:  Dis Markers        ISSN： 0278-0240            Impact factor:   3.434


In the article titled “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis” [1], the affiliation listed for Dr. O. Stasikowska-Kanicka and Dr. M. Wagrowska-Danilewicz was incorrect. The corrected authors' list and affiliations are shown above.
  1 in total

1.  Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis.

Authors:  L Durko; W Wlodarski; O Stasikowska-Kanicka; M Wagrowska-Danilewicz; M Danilewicz; P Hogendorf; J Strzelczyk; E Malecka-Panas
Journal:  Dis Markers       Date:  2017-06-04       Impact factor: 3.434
  1 in total
  2 in total

Review 1.  Markers of pancreatic cancer stem cells and their clinical and therapeutic implications.

Authors:  Arkadiusz Gzil; Izabela Zarębska; Wiktor Bursiewicz; Paulina Antosik; Dariusz Grzanka; Łukasz Szylberg
Journal:  Mol Biol Rep       Date:  2019-09-05       Impact factor: 2.316

2.  Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors.

Authors:  Seema C Parte; Surinder K Batra; Sham S Kakar
Journal:  J Ovarian Res       Date:  2018-08-18       Impact factor: 4.234
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.